Terumo has received the device for evaluation; however, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.No patient involvement.No clinical signs, symptoms or conditions.Defective component.Results pending completion of investigation.Conclusion not yet available.
|
The user facility reported to terumo cardiovascular that prior to cardiopulmonary bypass, during setup, after the water connections were secure from the oxygenator to the heater cooler, the fibers began to fill up with fluid.No patient involvement.The product was changed out.Procedure was completed successfully.
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on february 10, 2021.Upon further investigation of the reported event, the following information is new and/or changed: h6 (identification of evaluation codes 10, 3331, 213, 67).Type of investigation #1: 10 - testing of actual/suspected device.Type of investigation #2: 3331 - analysis of production records.Investigation findings: 213 - no device problem found.Investigation conclusions: 67 - no problem detected.The actual sample was visually inspected upon receipt with no anomaly including a breakage.The water channel of the actual sample was filled with colored water and a pressure of 3kgf/cm2 was applied, no leakage was observed.The blood channel was then filled with saline solution and a pressure of 2kgf/cm2 was applied.No leakage was observed.The evaluation result found that there was no anomaly in the actual sample; therefore, a root cause could not be determined.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|